Abstract:Obesity/diabetes adversely affects ischemic heart remodeling via incompletely understood mechanisms. Adipocytes produce various adipokines. Delineating these adipokines’ cardiovascular profiles is critical in advancing our knowledge regarding how obesity/diabetes may cause cardiovascular damage. C1q/TNF-related protein-3 (CTRP3) is a newly identified adipokine exerting beneficial metabolic regulation. However, the cardiovascular actions of this novel adipokine remain unknown. The current study determined whether CTRP3 may regulate post-ischemic cardiac remodeling and cardiac dysfunction, and, if so, sought to elucidate the involved underlying mechanisms. Male adult mice were subjected to MI, and treated with saline or CTRP3 via peritoneally implanted osmotic-pumps for 2 weeks. Plasma CTRP3 levels were significantly reduced 4 hours after MI, and remained at low level until 1 week after MI. Supplementation of CTRP3 (beginning 4 hours after MI) at a dose (0.25 μg/g/day) restoring physiological CTRP3 levels in MI animals improved survival rate (P<0.05), rescued cardiac function (determined by echocardiograph and left ventricular catheterization, P<0.01), attenuated cardiomyocyte apoptosis within infarct border zones (determined by TUNEL staining and caspase 3 activation, P<0.01), increased revascularization (evidenced by CD31 and α-SMA immunostaining, P<0.01), and dramatically reduced interstitial fibrosis (41% reduction vs. vehicle group, P<0.01). In vivo CTRP3 administration had no significant effect upon AMPK phosphorylation, but significantly increased Akt phosphorylation, and increased HIF-1α and VEGF expression. Surprisingly, treatment of HUVECs in vitro with CTRP3 failed to increase tube formation. However, pre-conditioned medium from CTRP3-treated cardiomyocytes significantly enhanced HUVEC tube formation, an effect that was blocked by either pre-treatment of cardiomyocytes with a PI3K inhibitor, or pre-treatment of HUVECs with a VEGF inhibitor. Our results demonstrate for the first time that CTRP3 is a novel anti-apoptotic, pro-angiogenic, and cardioprotective adipokine in the ischemic mouse heart, via facilitation of cardiomyocyte-endothelium communication.

C1q/tumor necrosis factor-related protein-6 attenuates TNF-α-induced apoptosis in salivary acinar cells via AMPK/SIRT1-modulated miR-34a-5p expression.

CTRP3 promotes TNF-α-induced apoptosis and barrier dysfunction in salivary epithelial cells

CTRP6 promotes the macrophage inflammatory response, and its deficiency attenuates LPS-induced inflammation

C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation

CTRP6 Regulates Porcine Adipocyte Proliferation and Differentiation by the AdipoR1/MAPK Signaling Pathway.

Lentivirus-mediated CTRP6 Silencing Ameliorates Diet-Induced Obesity in Mice.

Adipokine CTRP6 Improves PPARγ Activation to Alleviate Angiotensin II-induced Hypertension and Vascular Endothelial Dysfunction in Spontaneously Hypertensive Rats.

Knockdown of CTRP6 Inhibits Adipogenesis Via Lipogenic Marker Genes and Erk1/2 Signalling Pathway

CTRP6 Inhibits PDGF-BB-induced Vascular Smooth Muscle Cell Proliferation and Migration

C1q/TNF‐related Protein 6 (CTRP6) Attenuates Renal Ischaemia‐reperfusion Injury Through the Activation of PI3K/Akt Signalling Pathway

Toll-like receptor 9 signaling promotes autophagy and apoptosis via divergent functions of the p38/JNK pathway in human salivary gland cells.

SIRT6 Inhibits TNF-α-induced Inflammation of Vascular Adventitial Fibroblasts Through ROS and Akt Signaling Pathway.

Inhibition of CTRP6 Prevented Survival and Migration in Hepatocellular Carcinoma Through Inactivating the AKT Signaling Pathway.

CTRP6-mediated cardiac protection in heart failure via the AMPK/SIRT1/PGC-1α signalling pathway

C1QTNF6 Promotes Oral Squamous Cell Carcinoma by Enhancing Proliferation and Inhibiting Apoptosis

C1q/Tumor Necrosis Factor-Related Protein-9 Enhances Macrophage Cholesterol Efflux and Improves Reverse Cholesterol Transport via AMPK Activation

Claudin-3 is Required for Modulation of Paracellular Permeability by TNF-α Through ERK1/2/slug Signaling Axis in Submandibular Gland.

Abstract 8965: C1q/TNF-Related Protein-3, a Newly Identified Adipokine, is a Novel Anti-Apoptotic, Pro-Angiogenic, and Cardioprotective Molecule in the Ischemic Mouse Heart

C1q/Tumor Necrosis Factor-Related Protein-9, A Novel Adipocyte-Derived Cytokine, Attenuates Adverse Remodeling In The Ischemic Mouse Heart Via Protein Kinase A Activation

C6-ceramide Induces Salivary Adenoid Cystic Carcinoma Cell Apoptosis Via IP3R-activated UPR and UPR-independent Pathways.

CTRP9 Promotes Brown Adipose Tissue Lipolysis in Mice Fed a High-Fat Diet